Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant Topical Intranasal Steroid to Prevent Tolerance and Rebound Congestion Due to Regular Oxymetazoline in Persistent Allergic Rhinitis
NCT00846326Phase 4Withdrawn
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluticasone propionate nasal spray in allergic rhinitis (AR), Tachyphylaxis, rhinitis medicamentosa (RM). Status: withdrawn.
02
Drugs
fluticasone propionate nasal spray
03
Conditions
allergic rhinitis (AR)Tachyphylaxisrhinitis medicamentosa (RM)
Beyond the preview
Go deeper on NCT00846326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00846326.